CC
TEVA icon

Corsicana & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Corsicana & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75
Closed -$2.34K – 282
2025
Q4 		$2.34K Hold
75
– – ﹤0.01% 244
2025
Q3 		$1.51K Buy
+75
New +$1.32K ﹤0.01% 251
2022
Q3 		$1K Hold
100
– – ﹤0.01% 206
2022
Q2 		$1K Hold
100
– – ﹤0.01% 209
2022
Q1 		$1K Hold
100
– – ﹤0.01% 211
2021
Q4 		$1K Hold
100
– – ﹤0.01% 208
2021
Q3 		$1K Hold
100
– – ﹤0.01% 209
2021
Q2 		$1K Buy
+100
New +$1.06K ﹤0.01% 202

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corsicana & Co's TEVA Position: Q1 2026 in Review

Corsicana & Co sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 75 shares — an estimated $2.34K sold.

Corsicana & Co first reported a position in TEVA in Q2 2021 and held it in 8 quarters. The position peaked at $2.34K in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Corsicana & Co reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Corsicana & Co sold 75 Teva Pharmaceuticals shares in Q1 2026, an estimated $2.34K.
  • Corsicana & Co first reported a position in Teva Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • Corsicana & Co's Teva Pharmaceuticals position peaked at $2.34K in Q4 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Corsicana & Co's 13F filing for Q1 2026, filed 13 May 2026.